| Medical and Health Sciences | Lifetime | 14 | US 7 | 100.00 |
| Medical and Health Sciences | 2021-2025 | 7 | US 5 | 100.00 |
| Cardiology and Cardiovascular Medicine | Lifetime | 1 | US 1 | 100.00 |
| Endocrinology, Diabetes and Metabolism | Lifetime | 11 | US 5 | 99.95 |
| Surgery | Lifetime | 594 | US 324 | 99.44 |
| Pulmonary and Respiratory Medicine | Lifetime | 445 | US 236 | 99.42 |
| Medical Physiology | Lifetime | 890 | US 457 | 98.33 |
| Complementary and Alternative Medicine | Lifetime | 469 | US 169 | 97.05 |
| Nephrology | Lifetime | 343 | US 164 | 97.08 |
| Hematology | Lifetime | 574 | US 289 | 95.66 |
| Emergency Medicine | Lifetime | 964 | US 511 | 87.74 |
| Cardiology and Cardiovascular Medicine | 2021-2025 | 4 | US 3 | 99.99 |
| Endocrinology, Diabetes and Metabolism | 2021-2025 | 6 | US 4 | 99.97 |
| Surgery | 2021-2025 | 237 | US 95 | 98.54 |
| Pulmonary and Respiratory Medicine | 2021-2025 | 432 | US 140 | 95.40 |
| Nephrology | 2021-2025 | 167 | US 63 | 92.41 |
| Hematology | 2021-2025 | 258 | US 120 | 89.37 |
| Cardiovascular Function and Risk Factors | Lifetime | 1 | US 1 | 100.00 |
| Heart Failure Treatment and Management | Lifetime | 1 | US 1 | 100.00 |
| Cardiac pacing and defibrillation studies | Lifetime | 2 | US 2 | 99.98 |
| Diabetes Treatment and Management | Lifetime | 2 | US 1 | 99.97 |
| Potassium and Related Disorders | Lifetime | 1 | US 1 | 99.98 |
| Hormonal Regulation and Hypertension | Lifetime | 9 | US 4 | 99.86 |
| Electrolyte and hormonal disorders | Lifetime | 10 | US 5 | 99.70 |
| Cardiac electrophysiology and arrhythmias | Lifetime | 43 | US 23 | 99.80 |
| Blood Pressure and Hypertension Studies | Lifetime | 50 | US 24 | 99.75 |
| Health Systems, Economic Evaluations, Quality of Life | Lifetime | 87 | US 43 | 99.63 |
| Erythropoietin and Anemia Treatment | Lifetime | 13 | US 5 | 99.51 |
| Pancreatic function and diabetes | Lifetime | 102 | US 50 | 99.58 |
| Atrial Fibrillation Management and Outcomes | Lifetime | 107 | US 52 | 99.64 |
| Heart rate and cardiovascular health | Lifetime | 5 | US 2 | 99.26 |
| Medication Adherence and Compliance | Lifetime | 30 | US 23 | 99.17 |
| Diabetes Management and Research | Lifetime | 137 | US 73 | 99.38 |
| Cardiac Imaging and Diagnostics | Lifetime | 404 | US 216 | 99.31 |
| Cardiac Arrhythmias and Treatments | Lifetime | 416 | US 207 | 98.88 |
| Lipoproteins and Cardiovascular Health | Lifetime | 274 | US 143 | 98.75 |
| Metabolism, Diabetes, and Cancer | Lifetime | 332 | US 151 | 98.67 |
| Cardiac, Anesthesia and Surgical Outcomes | Lifetime | 788 | US 394 | 98.48 |
| Cardiac Structural Anomalies and Repair | Lifetime | 394 | US 254 | 98.81 |
| Nitric Oxide and Endothelin Effects | Lifetime | 362 | US 172 | 98.42 |
| Acute Myocardial Infarction Research | Lifetime | 389 | US 186 | 98.77 |
| Renin-Angiotensin System Studies | Lifetime | 152 | US 66 | 98.18 |
| Dialysis and Renal Disease Management | Lifetime | 348 | US 144 | 98.30 |
| Pulmonary Hypertension Research and Treatments | Lifetime | 387 | US 179 | 98.02 |
| Cardiac Health and Mental Health | Lifetime | 273 | US 155 | 97.97 |
| Cardiac Fibrosis and Remodeling | Lifetime | 136 | US 58 | 97.79 |
| Heart Rate Variability and Autonomic Control | Lifetime | 632 | US 287 | 98.03 |
| Chronic Kidney Disease and Diabetes | Lifetime | 316 | US 141 | 98.20 |
| Cardiovascular and exercise physiology | Lifetime | 510 | US 194 | 97.88 |
| Iron Metabolism and Disorders | Lifetime | 425 | US 193 | 97.42 |
| Pharmaceutical Economics and Policy | Lifetime | 276 | US 137 | 96.31 |
| Mechanical Circulatory Support Devices | Lifetime | 822 | US 460 | 97.01 |
| Cardiovascular Issues in Pregnancy | Lifetime | 592 | US 251 | 95.79 |
| Coenzyme Q10 studies and effects | Lifetime | 275 | US 91 | 90.42 |
| GDF15 and Related Biomarkers | Lifetime | 342 | US 125 | 86.05 |
| Advanced Causal Inference Techniques | Lifetime | 907 | US 545 | 83.23 |
| Cardiovascular Function and Risk Factors | 2021-2025 | 5 | US 4 | 99.97 |
| Heart Failure Treatment and Management | 2021-2025 | 2 | US 2 | 99.98 |
| Diabetes Treatment and Management | 2021-2025 | 5 | US 4 | 99.96 |
| Pancreatic function and diabetes | 2021-2025 | 4 | US 3 | 99.83 |
| Hormonal Regulation and Hypertension | 2021-2025 | 6 | US 4 | 99.67 |
| Cardiac pacing and defibrillation studies | 2021-2025 | 19 | US 8 | 99.68 |
| Electrolyte and hormonal disorders | 2021-2025 | 5 | US 3 | 98.57 |
| Potassium and Related Disorders | 2021-2025 | 5 | US 3 | 99.46 |
| Metabolism, Diabetes, and Cancer | 2021-2025 | 32 | US 16 | 98.95 |
| Diabetes Management and Research | 2021-2025 | 82 | US 56 | 98.66 |
| Erythropoietin and Anemia Treatment | 2021-2025 | 11 | US 7 | 98.47 |
| Health Systems, Economic Evaluations, Quality of Life | 2021-2025 | 332 | US 112 | 96.78 |
| Blood Pressure and Hypertension Studies | 2021-2025 | 219 | US 85 | 96.17 |
| Chronic Kidney Disease and Diabetes | 2021-2025 | 165 | US 61 | 95.94 |
| Cardiac, Anesthesia and Surgical Outcomes | 2021-2025 | 922 | US 321 | 93.13 |
| Nutrition and Health in Aging | 2021-2025 | 652 | US 91 | 93.54 |
| Cardiac electrophysiology and arrhythmias | 2021-2025 | 583 | US 157 | 92.93 |
| Mechanical Circulatory Support Devices | 2021-2025 | 626 | US 280 | 93.03 |
| Cardiac Structural Anomalies and Repair | 2021-2025 | 795 | US 352 | 92.01 |
| Acute Myocardial Infarction Research | 2021-2025 | 735 | US 178 | 91.88 |
| Cardiovascular Disease and Adiposity | 2021-2025 | 521 | US 131 | 87.12 |
| Frailty in Older Adults | 2021-2025 | 716 | US 147 | 90.06 |
| Dialysis and Renal Disease Management | 2021-2025 | 669 | US 153 | 89.72 |
| Iron Metabolism and Disorders | 2021-2025 | 792 | US 248 | 81.40 |
| GDF15 and Related Biomarkers | 2021-2025 | 172 | US 51 | 75.58 |
| Pharmacology and Obesity Treatment | 2021-2025 | 317 | US 141 | 79.13 |
| Neurological and metabolic disorders | 2021-2025 | 150 | US 36 | 75.61 |
| Cardiovascular Issues in Pregnancy | 2021-2025 | 896 | US 309 | 74.14 |
| Cardiovascular Syncope and Autonomic Disorders | 2021-2025 | 564 | US 182 | 73.90 |
| Statistical Methods in Clinical Trials | 2021-2025 | 894 | US 377 | 68.37 |
| Cardiac Fibrosis and Remodeling | 2021-2025 | 831 | US 186 | 63.93 |
| Ion Transport and Channel Regulation | 2021-2025 | 439 | US 137 | 65.98 |
| Advanced Causal Inference Techniques | 2021-2025 | 930 | US 484 | 53.89 |
| Phosphodiesterase function and regulation | 2021-2025 | 304 | US 62 | 50.20 |
| Heart rate and cardiovascular health | 2021-2025 | 279 | US 51 | 27.43 |